Dextromethorphan for treatment of complex partial seizures.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 2314601.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We performed a double-blind, crossover, add-on study of the antitussive agent dextromethorphan (DM 120 mg/d) as therapy for seizures on 9 patients suffering from severe complex partial seizures. DM had no significant influence on key laboratory values, nor on anticonvulsant drug levels. Side effects were negligible. Complex partial seizure frequency increased 25% during the DM arm of the study, although this increase was not clinically significant.
Medical subject headings
- Dextromethorphan
- Epilepsy, Temporal Lobe
- Levorphanol